Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
826.00    16.00 (1.98%)
Bid:
832.00
Ask:
844.00
Spread: 12.00 (1.442%)
Market Cap: £226.08m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Director/PDMR Shareholding

3 Mar 2015 16:37

RNS Number : 4432G
Gooch & Housego PLC
03 March 2015
Β 

ο»Ώ

Annex DTR3

Β 

NotificationΒ of Transactions of Directors and Connected Persons

Β 

Β 

Β 

All relevant boxes should be completed inblock capital letters.

1.

Name of the issuer

Β 

Β 

Β 

Β 

Β 

Β 

Gooch & Housego plc

2.

State Β whether Β the Β notification Β relates Β to Β (i) Β a

transaction notified in accordance with DTR 3.1.2 R, (ii) Β a Β disclosure Β made Β in Β accordance Β with Β LR

9.8.6R(1) Β or Β (iii) Β a Β disclosure Β made Β in Β accordance

with section 793 of the Companies Act (2006).

Β 

Β 

DTR 3.1.2 R

3.

Name of director

Β 

Β 

Β 

Β 

Β 

Gareth Jones

Β 

Β 

Β 

Β 

4.

State Β whether Β notification Β relates Β to Β a Β person

connected Β with Β a Β director named in 3 and identify the connected person

Β 

Β 

Β 

N/A

5.

Indicate whether the notification is in respect of a

holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Β 

Β 

3

6.

Description of shares (including class), debentures or

derivatives or financial instruments relating to shares

Β 

Β 

Β 

Ordinary Shares of 20 pence each

7.

Name of registered shareholders(s) and, if more

than one, the number of shares held by each of them

Β 

Β 

Gareth Jones 45,468

Β 

Β 

8

State the nature of the transaction

Β 

Β 

Β 

Exercise & sale of share options with an exercise price of zero pence per share

9.

Number Β of Β shares, Β debentures Β or Β financial

instruments relating to shares acquired

Β 

Β 

Β 

62,900 Ordinary Shares of 20 pence each

10.

Percentage of issued class acquired (treasury shares of

that Β class Β should Β not Β be Β taken Β into Β account Β when calculating percentage)

Β 

Β 

0.26% of total issued share capital

Β 

11.

Number Β of Β shares, Β debentures Β or Β financial

instruments relating to shares disposed

Β 

Β 

Β 

62,900 Ordinary Shares of 20 pence each

12.

Percentage of issued class disposed (treasury shares of

that Β class Β should Β not Β be Β taken Β into Β account Β when calculating percentage)

Β 

Β 

0.26% of total issued share capital

Β 

Β 

13.

Price per share or value of transaction

Β 

Β 

705p

14.

Date and place of transaction

Β 

Β 

3 March 2015

15.

Total Β holding Β following Β notification Β and Β total

percentage Β holding Β following Β notification Β (any treasury shares should not be taken into account

when calculating percentage)

Β 

45,468 Ordinary Shares, equating to 0.19% of total issued share capital

16.

Date issuer informed of transaction

Β 

Β 

Β 

Β 

Β 

3 March 2015

IfΒ aΒ personΒ discharging managerial responsibilities hasΒ been granted options by the issuer completeΒ the followingΒ boxes

17

Date of grant

18.

Period during which or date on which exercisable

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class

and number)

21.

Exercise Β price Β (if Β fixed Β at Β time Β of Β grant) Β or

indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which

options held following notification

Β 

23.

Any additional information

Β 

Β 

N/A

24.

Name of contact and telephone number for queries

Β 

Andrew Boteler

(Chief Financial Officer)

Β 

NameΒ ofΒ authorisedΒ officialofΒ issuerΒ responsibleΒ forΒ makingΒ notification: Andrew Boteler

Β 

DateΒ ofΒ notificationΒ 3 March 2015

Β 

Β 

Β 

Β 

Notes: Β ThisΒ formΒ is intended foruseΒ by anΒ issuer toΒ make aΒ RIS notification required byDTRΒ 3.1.4.

Β 

(1) AnΒ issuerΒ makingΒ aΒ notificationΒ inΒ respectΒ ofΒ aΒ transactionΒ relatingΒ toΒ theΒ sharesΒ or debenturesofΒ the issuerΒ shouldΒ complete boxes 1Β to 16, 23Β and 24.

(2) AnΒ issuerΒ makingΒ aΒ notificationΒ inΒ respectΒ ofΒ aΒ derivativeΒ relatingΒ theΒ sharesΒ ofΒ the

issuerΒ shouldΒ complete boxes 1Β to 4,Β 6, 8,13, 14, 16, 23and 24.

(3) AnΒ issuerΒ makingΒ aΒ notificationΒ inΒ respectΒ ofΒ optionsΒ grantedΒ toΒ aΒ directorΒ shouldΒ complete boxesΒ 1Β to 3 and 17Β to 24.

(4) AnΒ issuermakingΒ aΒ notificationΒ inΒ respectΒ ofΒ aΒ financialΒ instrumentΒ relatingΒ toΒ the sharesΒ ofΒ theΒ issuer (otherΒ thanΒ a debenture) shouldΒ complete boxesΒ 1Β toΒ 4, 6, 8,Β 9,Β 11,

13, 14, 16, 23Β and 24.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

PageΒ 2

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSQXLFBEXFXBBE
Date   Source Headline
9th May 20197:00 amRNSNotification of Half Year Results
30th Apr 20197:00 amRNSAppointment of Chief Financial Officer
9th Apr 20197:00 amRNSCapital Markets Day
9th Apr 20197:00 amRNSHalf Year Trading Update
28th Mar 20195:28 pmRNSDirector/PDMR Shareholding
28th Mar 20195:25 pmRNSDirector/PDMR Shareholding
28th Mar 20195:24 pmRNSDirector/PDMR Shareholding
25th Mar 20195:24 pmRNSDirector/PDMR Shareholding
13th Mar 20197:00 amRNSITL signs manufacturing agreement with OrganOx
25th Feb 201911:27 amRNSDirector Share Purchase
21st Feb 20192:58 pmRNSDirector Share Purchase
20th Feb 20191:07 pmRNSResult of AGM
20th Feb 20197:00 amRNSAGM Trading Update
9th Jan 201910:17 amRNSGrant of LTIP Awards
9th Jan 20197:00 amRNSSite Visit to ITL Life Science Business
28th Dec 201811:14 amRNSBlock Listing Six Monthly Return
28th Dec 201811:13 amRNSIssue of Equity and Total Voting Rights
28th Dec 201811:12 amRNSBlock Listing Application
11th Dec 20184:44 pmRNSAdditional Listing
11th Dec 20187:00 amRNSPosting of Annual Report and AGM Notice
5th Dec 201811:30 amRNSDirector/PDMR Shareholding
5th Dec 201811:28 amRNSDirector/PDMR Shareholding
27th Nov 201811:36 amRNSDirector/PDMR Shareholding
27th Nov 20187:00 amRNSCFO Succession
27th Nov 20187:00 amRNSPreliminary Results
30th Oct 201811:06 amRNSHolding(s) in Company
29th Oct 201811:08 amRNSHolding(s) in Company
25th Oct 20184:40 pmRNSHolding(s) in Company
25th Oct 20187:00 amRNSNotification of Preliminary Results
23rd Oct 201810:23 amRNSHolding(s) in Company
4th Oct 20187:00 amRNSFull Year Trading Update
26th Sep 20189:00 amRNSHolding(s) in Company
6th Sep 20187:00 amRNSAerospace and Defence Acquisition
8th Aug 20187:00 amRNSLife Sciences Acquisition
12th Jul 20189:26 amRNSHolding(s) in Company
13th Jun 201810:08 amRNSHolding(s) in Company
6th Jun 20182:02 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSInterim Results
3rd May 20187:00 amRNSNotification of Half Year Results
6th Apr 20187:00 amRNSHalf Year Trading Update
3rd Apr 20184:35 pmRNSPrice Monitoring Extension
20th Mar 20188:25 amRNSHolding(s) in Company
21st Feb 20185:20 pmRNSResult of AGM
21st Feb 20187:00 amRNSAGM Trading Update
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
18th Jan 20181:35 pmRNSGrant of LTIP Awards
22nd Dec 20179:13 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.